Page last updated: 2024-08-25

n-acetylhistidine and Injury, Myocardial Reperfusion

n-acetylhistidine has been researched along with Injury, Myocardial Reperfusion in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Karck, M; Koch, A; Loganathan, S; Radovits, T; Sack, FU; Szabó, GB	1

Other Studies

1 other study(ies) available for n-acetylhistidine and Injury, Myocardial Reperfusion

Article	Year
Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection. Interactive cardiovascular and thoracic surgery, 2010, Volume: 10, Issue:2 Topics: Animals; Cold Ischemia; Deferoxamine; Glucose; Heart Transplantation; Histidine; Hydroxamic Acids; Iron Chelating Agents; Male; Mannitol; Myocardial Contraction; Myocardial Reperfusion Injury; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Rats; Rats, Inbred Lew; Stroke Volume; Time Factors; Ventricular Function, Left	2010

Article

Year

Deferoxamine, the newly developed iron chelator LK-614 and N-alpha-acetyl-histidine in myocardial protection.

Interactive cardiovascular and thoracic surgery, 2010, Volume: 10, Issue:2

Topics: Animals; Cold Ischemia; Deferoxamine; Glucose; Heart Transplantation; Histidine; Hydroxamic Acids; Iron Chelating Agents; Male; Mannitol; Myocardial Contraction; Myocardial Reperfusion Injury; Organ Preservation; Organ Preservation Solutions; Potassium Chloride; Procaine; Rats; Rats, Inbred Lew; Stroke Volume; Time Factors; Ventricular Function, Left

2010